First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis

View source ↗

Summary

The EMA recommends the first oral medicine that targets the interleukin-23 receptor for plaque psoriasis, showing potential to clear skin lesions in many patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ICOTYDE (ICOTROKINRA)

Snippet

Icotyde shown to clear psoriasis skin lesions in many patients with moderate to-severe plaque psoriasis